D-0257-2024 Class III Ongoing

Recalled by Amerisource Health Services LLC — Columbus, OH

FDA drug recall D-0257-2024 was initiated by Amerisource Health Services LLC on Dec 26, 2023 and is designated Class III. Reason for recall: Superpotent drug: Assay results were slightly above specification at the time zero point. The recall status is ongoing. Affected quantity: 6,344 cartons.

Recall details

Product Type
Drugs
Report Date
Jan 31, 2024
Initiation Date
Dec 26, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,344 cartons

Product description

Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11

Reason for recall

Superpotent drug: Assay results were slightly above specification at the time zero point.

Distribution pattern

Nationwide in the USA

Code information

Lot # 1014208, Exp Mar/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0257-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0257-2024. Report a data issue: hello@regdatalab.com.